U.S. Markets open in 1 hr 23 mins
  • S&P Futures

    3,944.25
    +46.50 (+1.19%)
     
  • Dow Futures

    31,490.00
    +288.00 (+0.92%)
     
  • Nasdaq Futures

    12,068.50
    +190.25 (+1.60%)
     
  • Russell 2000 Futures

    1,801.50
    +26.60 (+1.50%)
     
  • Crude Oil

    112.82
    +0.61 (+0.54%)
     
  • Gold

    1,840.00
    -1.20 (-0.07%)
     
  • Silver

    21.94
    +0.04 (+0.17%)
     
  • EUR/USD

    1.0574
    -0.0013 (-0.1269%)
     
  • 10-Yr Bond

    2.8550
    0.0000 (0.00%)
     
  • Vix

    28.55
    -2.41 (-7.78%)
     
  • GBP/USD

    1.2473
    -0.0002 (-0.0175%)
     
  • USD/JPY

    128.0000
    +0.2060 (+0.1612%)
     
  • BTC-USD

    30,402.53
    +968.54 (+3.29%)
     
  • CMC Crypto 200

    678.96
    +26.72 (+4.10%)
     
  • FTSE 100

    7,441.67
    +138.93 (+1.90%)
     
  • Nikkei 225

    26,739.03
    +336.19 (+1.27%)
     

Histogen to Report Second Quarter 2020 Earnings on August 13, 2020

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Histogen’s financial results for the second quarter ended June 30, 2020 will be released after the close of market on Thursday, August 13, 2020.

About Histogen Inc.

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com